Dana Lueck-Mammen
Lawyers
Filters
Aligos Therapeutics $92 million private placement
The PIPE included common stock and warrants
Marvell Technology $1 billion senior notes offering
The senior notes are due 2029 and 2033
Natera $250 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Weyerhaeuser $750 million notes offering
The investment-grade notes are due 2026
HilleVax $200 million IPO
The shares are listed on the Nasdaq Global Select Market
Credo Technology Group $200 million IPO
We advised Credo Technology on its IPO and Nasdaq listing
NVIDIA $5 billion senior notes offering
We advised the joint book-running managers on an investment-grade debt offering
Globe Life $325 million junior subordinated debt offering
We advised the underwriters on the SEC-registered offering
Connect Biopharma $219.9 million IPO
We advised the underwriters on the IPO and Nasdaq listing